GlassScriptPhysician profile
Praful Patel
NPI 1821020074
$64,886.66
in general payments reported to CMS, 2019-2025
30 companies · $15K in 2025
The $15K reported for 2025 was more than what 99% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $965 · 2020: $363 · 2021: $691 · 2022: $1,900 · 2023: $19K · 2024: $27K · 2025: $15K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $52K · Travel and Lodging: $4,753 · Food and Beverage: $2,824 · Education: $1,120.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $52,272.50 |
| Travel and Lodging | $4,752.91 |
| Food and Beverage | $2,823.54 |
| Education | $1,119.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $57,828.69 | 2019-2025 | Veozah, Myrbetriq |
| Intuitive Surgical, INC. | $3,543.75 | 2022-2024 | |
| Abbvie INC. | $885.59 | 2019-2025 | |
| Hologic Sales and Service, LLC | $639.15 | 2019-2025 | Novasure, Myosure Tissue Removal Device, Coolseal Generator |
| Coloplast Corp | $437.66 | 2020-2025 | |
| Mayne Pharma Commercial LLC | $258.87 | 2021-2023 | |
| Pfizer INC. | $223.10 | 2019-2025 | |
| Sumitomo Pharma America, INC. | $212.64 | 2023-2025 | Myfembree, Gemtesa |
| Bayer Healthcare Pharmaceuticals INC. | $131.26 | 2019-2023 | |
| Exeltis, USA INC. | $121.54 | 2021-2023 | Slynd |
| Therapeuticsmd, INC. | $74.85 | 2019-2022 | |
| Amgen INC. | $71.95 | 2020-2025 | Evenity |
| Millicent US INC | $58.87 | 2020-2024 | Intrarosa, Femring |
| Urovant Sciences INC | $56.94 | 2022 | |
| Scynexis, INC. | $40.61 | 2022 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myovant Sciences INC. | $36.37 | 2021-2022 | |
| Organon LLC | $29.09 | 2022-2023 | Nexplanon |
| Coopersurgical, INC. | $25.21 | 2019 | |
| Solventum Corporation | $24.51 | 2025 | Prevena |
| Conmed Corporation | $22.15 | 2023 | Airseal |
| Davol INC. | $21.90 | 2020 | |
| Radius Health, INC. | $20.24 | 2020 | |
| Alexion Pharmaceuticals, INC. | $19.00 | 2019 | |
| Biohaven Pharmaceutical Holding Company LTD. | $17.18 | 2022 | |
| Merck Sharp & Dohme LLC | $15.98 | 2019 | |
| Shield Therapeutics INC | $15.58 | 2024 | |
| Duchesnay USA Incorporated | $14.60 | 2019 | |
| Medtronic, INC. | $13.76 | 2021 | |
| Avion Pharmaceuticals | $13.57 | 2019 | |
| Agile Therapeutics, INC. | $12.05 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Praful Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.